2020

Portefølje Naturvitenskap og teknologi ikon

Forskningssystemet

Portefølje Humaniora og samfunnsvitenskap ikon

Banebrytende forskning

Portefølje Samisk ikon

Samisk samfunn og kultur

Portefølje Demokrati, styring og fornyelse ikon

Demokrati og global utvikling

Portefølje Velferd, kultur og samfunn ikon

Velferd og utdanning

Portefølje Helse ikon

Helse

Portefølje Klima- og polarforskning ikon

Klima og miljø

Portefølje Landbasert mat, miljø og bioressurser ikon

Mat og bioressurser

Portefølje Energi, transport og lavutslipp ikon

Energi og transport

Portefølje Muliggjørende teknologier ikon

Muliggjørende teknologier

Portefølje Industri og tjenestenæringer ikon

Innovasjon

LTP2 Klima, miljø og miljøvennlig energi ikon

Klima, miljø og energi

LTP2 Samfunnssikkerhet og samhørighet ikon

Samfunnstryggleik og beredskap

LTP2 Fornyelse i offentlig sektor ikon

Velferdstjenester

Forsidebilde

Marin ikon

Petroleum og mineraler

LTP Hav ikon

Hav og kyst

LTP2 Muliggjørende og industrielle teknologier ikon

Mogleggjerande industrielle teknologiar

Tillit og fellesskap

LTP2 Utvikle fagmiljøer av fremragende kvalitet

Høg kvalitet og tilgjengeleg

LTP2 Styrket konkurransekraft og innovasjonsevne ikon

Sterkare konkurransekraft og innovasjonsevne

LTP3 Helse

Et innovativt næringsliv ikon

Styrket konkurransekraft og innovasjonsevne

Portefolje Petroleum Ikon

Portefølje Hav ikon

Portefølje Utdanning og kompetanse ikon

Portefølje Global utvikling og internasjonale relasjoner ikon

Portefølje Livsvitenskap ikon

Forsidebilde optimalisert

project-bank-technical

Muliggjørende teknologier bakgrunn

Marin bakgrunnsbilde

Statistikk

Prosjektbanken presenterer statistikk og informasjon om prosjekter med finansiering fra Forskningsrådet fra 2004. Statistikken er fordelt på blant annet tema, år, geografi og organisasjon. Prosjektbanken gir også detaljert informasjon om de enkelte prosjektene.

...eller se sammendrag og annen informasjon om prosjektene i utvalget ditt

Alle porteføljestyrer

En god beskrivelse av denne siden for søkemotoroptimalisering

Forside

Hvordan tildelingene fordeler seg på institusjoner, fylker, fagområder o.l....

Her er noen eksempler på søk du kan gjøre i Prosjektbanken

Alle langtidsplanmål

Veiledning: Hvordan bruke Prosjektbanken.no

Om Fritekstsøk

Ingen populærvitenskapelig framstilling tilgjengelig


Prosjektet med prosjektnummer {{project number}} ble ikke funnet

Teknisk beskrivelse

Oisann, her gikk noe galt. Kan du prøve å laste siden på nytt?  Dersom feilen vedvarer, vennligst kontakt oss.         

Se statistikk relatert til dette langtidsplanmålet

Se prosjekter relatert til dette langtidsplanmålet

knyttet til dette LTP-målet har blitt tildelt penger

har blitt tildelt til prosjekter knyttet til dette LTP-målet

har blitt tildelt til prosjekter knyttet til denne porteføljen

knyttet til denne porteføljen har blitt tildelt penger

Om Prosjektbanken

2009

2010

2011

2008

2004

2007

2005

2006

2012

2013

2015

2016

Kunnskapsdepartement

Helse- og omsorgsdep

Nærings- og fiskerid

Diverse

Fiskeri- og kystdepa

Helsedepartementet

Ukjent

Utenriksdepartemente

Medisin og helsefag

Trøndelag - Trööndelage

LTP3 Styrket konkurransekraft og innovasjonsevne

LTP3 Et kunnskapsintensivt næringsliv i hele landet

LTP3 Høy kvalitet og tilgjengelighet

LTP3 Fagmiljøer og talenter

LTP3 Rettede internasjonaliseringstiltak

LTP3 Muliggjørende og industrielle teknologier

LTP3 Nano-, bioteknologi og teknologikonvergens

UoH-sektor

Portefølje Forskningssystemet

Portefølje Helse

Portefølje Muliggjørende teknologier

Portefølje Banebrytende forskning

Portefølje Innovasjon

Programmer

Frittstående prosjekter

Forskerprosjekt

Ingen søknadstype

Annen prosjektstøtte (t.o.m. 2014)

Politikk- og forvaltningsområder

Bransjer og næringer

Internasjonalisering

Anvendt forskning

Bioteknologi

Grunnforskning

BOLD MINDS aspires to enhance the understanding of vulnerability factors underlying the emergence of borderline personality disorder (BPD), with an ultimate aim of increasing the potential for young individuals to receive early, evidence-based help when their mental health is at risk. BOLD MINDS will achieve this by investigating whether disruptions in two aspects of autobiographical memory (AM), narrative identity (NI) and involuntary AM (IAM), are associated with BPD features and problem behaviours in adolescents concurrently and over time. In doing so, BOLD MINDS will strengthen the understanding of mechanisms underlying the emergence of BPD in adolescence and lay a groundwork for developing evidence-based early interventions for BPD. While currently limited, the study of AM in this field is essential for two reasons. Firstly, because the aspects of AM under investigation, NI and IAM, are known to be involved in identity formation and emotion regulation which represent two key psychological processes that are disrupted in adults with BPD and are linked to problem behaviours such as self-harm and suicidality. Secondly, because promising research is emerging on the use of AM targets in the treatment of emotional disorder in adults, and provides a strong model for future treatment development with vulnerable adolescents. In addition, this timely research program aligns with calls from international organizations to prioritize early interventions to promote adolescent mental health. BOLD MINDS will adopt and adapt state-of-the-art ecological momentary assessment and analytical techniques and work at the crossroads of clinical and cognitive psychological perspectives, allowing for a multidimensional approach to understanding BPD vulnerability. Training-through-research and formalized training of the experienced researcher will prepare her for a permanent academic position and the founding of her own research lab specializing in AM and early interventions for BPD.

Borderline Personality Disorder: Memory and Identity in Adolescence

Bilingual Experiences, Cognitive Ageing and underlying Mechanisms

The goal of the Bilingual Experiences, Cognitive Ageing and underlying Mechanisms (BECAME) project is to examine the functional neuroplastic mechanisms underlying mitigatory effects of bilingual experience on age-related cognitive decline. While evidence is available for structural brain changes supporting bilingualism-induced effects on cognitive aging (CA), functional mechanisms underlying such effects are not yet well understood. BECAME aims to fill this gap by investigating the trajectory of bilingualism-induced functional neuroplasticity across the adult lifespan (ages 18-85), crucially adopting an individual differences approach related to measurable degree of bilingual engagement. Importantly, although such benefits are thought to be rooted early in the lifespan, evidence for the timeframe and conditions of their early emergence is scarce. The choice of including the whole adult lifespan allows us to investigate these mechanisms and their emergence more directly from a lifespan perspective. I combine behavioral testing with brain recordings via electroencephalography (EEG). EEG is widely used in cognitive neuroscience to assess brain activity and the degree of communication between brain regions (functional connectivity) in response to stimuli and at rest. Combining behavioral and EEG modalities will allow me to test bilingualism’s effect on functional connectivity, as well as its consequences for functional efficiency, the minimum required neural activation to successfully perform a task. This will enable a detailed, evidence-based account of the protective effects observed in older-aged bilinguals, and how they are built from earlier life stages. By illuminating the relationship between multilingualism and resulting neurocognitive adaptations, BECAME will enable to capitalize on it as a health initiative, with manifold societal implications and the potential to be translated into actionable policies exploiting multilingualism to ameliorate effects of CA.

WHeelchair Activity Monitoring project (WHAM)

Wheelchair users (WCU) are three to five times more inactive than the general population, leading to a high risk of developing preventable secondary conditions. Although physical activity (PA) guidelines have been specifically developed for WCU, we lack systematic approaches to implement them in practice, as well as valid algorithms to monitor PA change in WCU through sensor-based solutions. Accordingly, the overall scientific aim of the WHeelchair Activity Monitoring project (WHAM) is to advance PA research and practice in WCU by developing valid digital markers for monitoring of and providing feedback on PA, paving the way for implementation and intervention. I will accomplish this through combining the complementary research fields of 1) behavioural intervention studies focusing on increasing PA in WCU (core competence University of British Columbia, UBC; outgoing phase) and 2) sensor-based PA monitoring (core competence Norwegian University of Science and Technology, NTNU; returning phase – consolidated by non-academic placement at Maastricht Instruments, which develop research prototypes including PA monitors). WHAM’s scientific aim is achieved through three objectives: 1) Measure the effect of a pragmatic exercise intervention trial on self-reported physical activity levels and cardio-respiratory fitness, 2) Develop valid algorithms for tracking PA markers in WCU, and 3) Co-create a framework that outlines how PA can be conjointly monitored and provided feedback on in WCU. This fellowship will enable me to become established as an internationally recognized researcher in the field of “physical activity and disability”, while bringing together ongoing national disjointed research activities in this field. Altogether, my overall ambition is to contribute to reducing inequalities in daily-life participation among WCU compared to the rest of the population.

Longitudinal Investigation of Visual and Numerical Perception in Preterm and Full-term Infants

The number of preterm births is on the rise -now more than 1 in 10 babies- and being born preterm is associated with having difficulties in two very important and related cognitive skills that we rely on daily: numerical and visual perception. However, a knowledge gap exists on neural and behavioural associations of numerical and visual perception in full-term and preterm infants. PrePER aims to uncover the underlying neural signatures of the cognitive dysfunctions that preterm infants might display in the first year of their lives and the role of parent-baby interaction to predict preterm infants that are at risk of developing these cognitive difficulties in the second year of their lives. The purpose is to establish criteria to identify infants (especially preterm) at-risk of having cognitive difficulties in numerical and visual perception. Shedding light on normal and impaired cognitive functions in infancy is an essential stepping stone that will pave the way for early diagnostic tools and interventions that would correct the cognitive dysfunctions more efficiently while the brain is still developing. The activities in PrePER will lead to original and innovative outcomes that are beneficial for four parties: 1) Scientific communities will be interested in the results as the ambitious research objectives address questions that have not been asked before. 2) Parents of preterm infants, health-care providers, and policy makers will be interested in the results as the overall aim is to establish criteria to identify infants at-risk of having cognitive-developmental difficulties in the first year of their lives. 3) The researcher will be accelerating her career progression as the training objectives meet her specific needs. 4) The supervisor will be enlarging her research interest and network as the research objectives include a topic within the researcher’s expertise.

AQUASERV – RESEARCH INFRASTRUCTURE SERVICES FOR SUSTAINABLE AQUACULTURE, FISHERIES AND THE BLUE ECONOMY

The overarching objectives of AQUASERV are to bring together, enhance, integrate and customise RI capacities (including facilities, instruments and expertise) and through the provision of transnational access (on-site or remote) and/or virtual access, to significantly further scientific advance and promote and facilitate the implementation of European Common Fisheries Policy, the Farm to Fork Strategy, the Sustainable Blue Economy and the European Green Deal. 

AQUASERV will achieve these objectives by offering scientists from academia and business remote and on-site transnational (TA) and virtual (VA) access to an advanced set of European research infrastructures and its nodes related to research and management of marine and freshwater biological resources, food and biotechnology. These include the European Marine Biological Resource Centre ERIC (EMBRC), the Analysis and Experimentation on Ecosystems ERIC, The Aquaculture for Excellence for Aquaculture in Fish (Aquaexcel), and the Infrastructure for Promoting Metrology in Food and Nutrition (METROFOOD), as well as the International Council for Exploration of the Sea, both a service provider and stakeholder. It also includes the Research Infrastructure for Science and Innovation Policy Studies (RISIS) to bring contributions from the social sciences and to bring results nearer to policy makers ensuring societal impact. 

To enhance, integrate and customise RI capacities, collaboration between partners and new pipelines to meet the objectives of the project will be developed during the first 3 years and will make available  to users.  To ensure these capacities will not be lost, a sustainability work package involving stakeholders will address the project legacy.  

To maximize impact, AQUASERV will build a communication network among the partnership and develop a dissemination and outreach programme. Furthermore, an advanced training programme will be developed to capture future users and will be updated during the p

IMProving User experience, Long-term sustainability and Services of EU-OPENSCREEN

EU-OPENSCREEN (EU-OS), the distributed European Research Infrastructure for Chemical Biology and early drug discovery, provides world-class services in high-throughput compound screening and medicinal chemistry to users from academia and industry. As one of the largest open-access initiative globally, EU-OPENSCREEN plays an increasingly important role in facilitating early stage drug discovery in Europe. It recently integrated fragment-based drug discovery and chemoproteomics as two new services, but the increasing complexity of modern drug discovery projects requires an even more comprehensive portfolio and integration of emerging technologies. To ensure that EU-OS continues to offer a comprehensive suite of relevant services and support a growing user community to conduct forefront research, IMPULSE will develop, validate and integrate new services in AI/ML, new chemical modalities, and innovative disease-relevant cell models combined with CRISPR-Cas9/RNAi-based genetic screening. IMPULSE will work towards the implementation of common operational and data standards to increase data reproducibility and FAIRness. Bespoke outreach and training activities will raise awareness among key user groups of its new services and advance operational excellence and reproducibility in pre-clinical drug discovery. New models for pre-competitive drug discovery with industry or charities, and growing ERIC member community will reinforce the sustainability and accessibility of EU-OPENSCREEN.

Strengthening resilience and mental wellbeing through the Support4Resilience toolbox for leaders in elderly care

European elderly care experiences labor shortages, lack of qualified workers and a mismatch between capacity and demands, causing stress, burnout, and reduced mental wellbeing among healthcare workers and informal caregivers. Leaders are crucial in promoting supportive working conditions but lack research-based measures to act upon these challenges.

Support4Resilience (S4R) will develop, implement, and evaluate a research-based Toolbox to support healthcare leaders in improving healthcare workers’ and informal caregivers’ resilience and mental wellbeing in elderly care. S4R will identify resilience and mental wellbeing factors among healthcare workers and informal caregivers; explore their perspectives and needs; develop new theory on the relationship between individual and organizational resilience, and mental wellbeing; and develop recommendations and cost-effective interventions. The Toolbox with tailormade resources for policy and practical use will be available through an open access S4R Resource Bank.

The S4R Toolbox includes three main tools: 1) Mapping and identification, 2) Reflection and education, and 3) Reorganization. Measures are initiated at the organizational level and effects on mental wellbeing and resilience transpire at the frontline of elderly care. The Toolbox covers different situational contexts, types of healthcare providers and health system levels. Elderly care settings in six European countries will implement and evaluate the Toolbox through a process evaluation, effectiveness evaluation, and cost-effectiveness evaluation. 

S4R provides policymakers, decisions-makers and leaders with solutions for taking action to solve specific risks for healthcare workers’ and informal caregivers’ resilience and mental wellbeing. Thus, pertinent to the work programme, S4R will support the development of resilient health systems in European elderly care through improved leadership capabilities, governance structures, and adaptive capacities.

NEXT GENERATION IMAGING FOR REAL-TIME DOSE VERIFICATION ENABLING ADAPTIVE PROTON THERAPY

The NOVO project will address a fundamental issue in proton radiotherapy (PT) of cancer, namely the lack of real-time dose verification (RDV) that significantly limits the potential of PT due to uncertainties in the precise delivery of the prescribed dose. In the NOVO project, we will develop the first proof-of-concept of an RDV technology adaptable to any PT treatment and bring the concept to TRL 4 by also considering integration into the PT clinical workflow. The RDV technology will be pivotal for enabling the next generation of adaptive PT therapy, i.e., dose-guided real-time adaptive therapy. Real-time measurement of the dose to targeted and non-targeted tissues will be the key to truly empower patient-centered, personalized cancer treatment, important to improve curation and quality-of-life post-treatment. As a high-risk/high-gain project, NOVO aims at a first-of-its-kind RDV technology through the unique synergy between (1) cutting-edge, inexpensive organic scintillator technology that can detect secondary radiation during treatment for non-invasive measurements, (2) novel and fast image reconstruction, artificial intelligence (AI)-accelerated models and AI-enhanced image reconstruction to allow simultaneous detection of multiple radiation species and tissue compositional analysis, (3) tumor-tracking and imaging of tissue radio-sensitivity based on oxygen levels, (4) intelligent automation of decision-making schemes for real-time dose-guided adaptive therapy. The project will essentially open a new era in PT that enables curing more cancer patients and reducing toxicity from treatment. The NOVO consortium covers the entire value chain of RDV development (technology providers, theory and modelling, technology integration and PT clinics) and optimally engages nuclear, medical, and high-energy physicists, chemists, mathematicians, computer scientists, oncologists, biologists, as well as European PT centers. 


Development of innovative proton and neutron therapies with high cancer specificity by 'hijacking' the intracellular chemistry of haem biosynthesis.

Deep-lying cancers, such as glioblastoma multiforme (GBM) brain cancer, are very difficult to access and incurable by the current standards of care. The fluorescence of photosensitive molecules (PSs) can precisely guide surgical resection of GBM. Nevertheless, photomedical treatments like photodynamic therapy (PDT) show limited efficacies due to the low penetration of light into tissue. Proton radiotherapy can reach deep-lying disease through therapeutic energy deposition in a spatially confined region called Bragg peak. Current neutron-based therapies, like Boron Neutron Capture Therapy (BNCT), have sufficient penetration depth but lack cancer specificity.
In NuCapCure, we propose to 'hijack' intracellular biosynthetic pathways and use them to produce custom-made drugs that will facilitate two genuinely new cancer treatments: i) "NuCapCure Proton", combining proton radiotherapy, protondynamic therapy through PS proton activation, and proton capture therapy (BPCT) through three produced alpha particles; and ii) "NuCapCure neutron", combining GBM specific BNCT and PS neutron activation as demonstrated in our FET-open project FRINGE.
The main scientific breakthroughs of NuCapCure will be to demonstrate the custom production of novel compounds through native intracellular biosynthesis but also to establish experimental proof-of-principle, both in vitro and in vivo, of the proposed two novel therapies. Our highly interdisciplinary project team comprises world-renowned experts from a unique combination of disciplines: proton and neutron physics, synthetic chemistry, photochemistry, photobiology, radiobiology, medical physics, nuclear reactor and particle accelerator technology and radio-oncology to lay the foundations for novel, targeted and curative therapies against currently fatal cancer indications like GBM.

Despites dental pulp capping materials should meet the certain requirements, the available materials have one or more shortcomings—poor biocompatibility and rheological properties, fail to maintain pulp vitality and to simulate reparative dentine formation and expensive etc. Mineral trioxide aggregate (MTA) is widely used material because of its beneficial properties. However, its composition bismuth oxide, which is suspectable to toxicity, has an impact on rheological properties. This emphasizes the necessity of looking for inexpensive alternatives to materials that meet the specifications. This project's goal and novelty are to investigate the potential processing of the dental pulp capping cement, which is made of strontium silicate (SrSiO3), strontium fluoride (SrF2), piezoelectric material (PZM) and tricalcium silicate (Ca3O5Si) and its rheological properties and hemocompatibility. Because SrSiO3, SrF2, PZM and Ca3O5Si have the promising properties. This project's work packages are split into four categories based on the interdisciplinary approach since it involves the synthesis and characterization of PZM, the processing and characterization of cement, the identification of rheological parameters utilizing ISO standardizations, and hemocompatibility, and acquiring new transferrable skills. Additionally, the interactions among the selected compounds will be determined. The scientific impact of this project is comprehending the physical properties and the immune system's response to evaluate the cement's suitability as a replacement for existing materials, as well as resulting in further uses in dentistry and medicine. The societal impact is providing millions of patients in Europe with predictable and outstanding treatment outcomes each year to maintain pulp vitality and health. Eventually, it will ease the financial load on millions of patients who need dental care, will be avoiding inflated medical expenses and misuse of the patent (economic impact).

SrSiO3-based Dental Pulp Capping Cement

Midlene fra BIO-1.02.Food, Agriculture and Fisheries, and Biotechnology fordelt på år

Midlene fra BIO-1.02.Food, Agriculture and Fisheries, and Biotechnology fordelt på fylker

Midlene fra BIO-1.02.Food, Agriculture and Fisheries, and Biotechnology fordelt på fagområde

Innovative non- intrusive laser gas sensors on food production for real time quality/safety  in line control of food packaging and bottling systems

EURO IMPACT aims to develop a multi-disciplinary, multi-professional and intersectorial
educational and research training network aimed at monitoring and improving palliative care in Europe. Palliative care is less than optimal in many developed countries  and some patients suffer from severe symptoms. While international research on palliative care has begun to develop over the past decades, it has not kept pace with the growing demand for high quality care. The increase in elderly people, chronic disease s and health care costs, makes the provision of enhanced research training in palliative care one of the most urgent societal challenges at EU level.
The training and research programme of EURO IMPACT are closely intertwined, involving 5
universities, 2 p rivate companies and 3 socio-economic actors, and training 12 early stage and 4 experienced researchers. The partners are at the forefront of palliative research training and represent a wide spectrum of disciplines and professions. The research training  involves researchers working together, with different methodologies and datasets gathered in different countries and from multiple perspectives. It will provide a broad overview on palliative care and its quality in Europe and identify tools to improve it . On-the-job training will be supplemented with structured courses concerning palliative care research and network-wide training on multi-disciplinary, ethics, cross-national research and societal dissemination. In order to influence policy and clinical p ractice
in palliative care, all partners and researchers are involved in societal dissemination of the training results to a wider national and international audience.
EURO IMPACT reduces current fragmentation of research training in palliative care and p rovides the new generation of European researchers with the necessary scientific and complementary skills to influence future palliative care at national and international level, and at practice and policy level.

Elene Janberidze - European Intersectorial and Multi-disciplinary Palliative Care Research Training

David Blum - European Intersectorial and Multi-disciplinary Palliative Care Research Training

This project will perform functional genomic research with a translational approach that will bring new scientific knowledge into the health care system. The project will identify gene polymorphisms and gene expression profiles that may confer  developmen t of lung cancer, and act as a prognostic marker for tumor stage and tumor- and symptom treatment. To bridge the gap between genomics and clinics, international endorsed computer assisted standards for symptom assessment and classification will be develop ed and serve as valid and reliable assessment for subjective symptoms. The impact from genotyping, gene expression and computer based symptom assessment/classification will be utilized in an artificial intelligent decision support system. The SNP genotypi ng (Illumina) will be performed on patients with lung cancer and controls from two regional representative health surveys (HUNT II and Tromsø IV), and a consecutive series of 100 lung cancer patients from the Central Norway Lung Cancer Biobank, followed b y a high density SNP mapping of the identified risk associated genes and loci. A similar approach will be used to study gene expression in peripheral blood leucocytes. The genetic information will be combined with clinical information in order to answer t he research questions. Content and type of items for a computer assisted symptom assessment/classification system will be decided from literature reviews and expert opinions. Lung cancer and palliative care patient cohorts will be used as informants to te st the performance of all items, the computer software and to investigate the final assessment tool. A functional specification of an artificial intelligent (AI) system will be developed, tested in lung cancer and palliative care patient cohorts. This wil l lead into a template of an AI decision support system for further research and possible clinical application.

Translational Research in Lung Cancer and Palliative Care - from genomics to symptom control

Regular physical activity promotes health. An inactive lifestyle may alter gene expression, influence negatively on several organ systems and thereby cause chronic disease and increase mortality. These conditions may be reversed by regular activity and in creased level of physical fitness. Physical activity and fitness also parallel QoL, reduced depression and improved social welfare. Patients with chronic pain report reduced physical function, lower muscular strength and aerobic fitness. There is an urgen t need to investigate these aspects in large scale epidemiological studies and in prospective cohort studies. Through the establishment of a long term interdisciplinary research collaborative with scientists from physical exercise, clinical research, epid emiology, outcome assessment, pharmacology and molecular biology at the Faculty of Medicine, NTNU including international collaborators, physical activity, pain and general health and genomics will be targeted. In the first phase of the collaborative, one  will scientifically investigate how physical activity may cause, modulate and prevent chronic pain, general health, major diseases as well as improvement of Quality of life (QoL). In the next phase the collaborative will embark on intervention studies. T he Nord-Trøndelag Health Survey (HUNT), the largest population based health study in Norway, is the basis for the collaboration in this phase of the research. The study material will consist of data from HUNT-2 and HUNT-3 (study I) supplied by two studies . One will test physical activity and capacity of a representative cohort of approximately 10000 participants (study II), a representative sample of HUNT-3. Furthermore, a prospective follow-up study (study III) of 3000 participants followed over a five y ear period, a representative draw from the 10000 cohort and HUNT-3. The overall goal is to establish a long lasting collaborative to investigate the effect of physical activity and capacity on health.

Physical activity and chronic pain in HUNT 3 - A prospective cohort study

The group was formally established in 2002 thanks to a research grant from Norwegian 
Research Council (NFR) (2001-2003). The group consist of core personnel in permanent positions at The Faculty of Medicine, 
NTNU and personnel supported by the above NFR  grants and other grants including NFR. The research groups comprise a broad 
spectrum of competence within clinical medicine, molecular biology, pharmacology and psychiatry/social sciences, as well as 
competent persons founding a good infrastructure for  the research. The group has conducted original research with opioid 
pharmacology and pharmacogenetics as well as subjective symptom assessment and control of symptoms. Clinical trials in 
palliative care and follow-up of cancer survivors have been a bas ic approach together with establishment of biobanks. We will 
now expand into non-malignant pain (which include post cancer morbidity), establish more specific (to understand pain 
mechanisms) or larger biobank samples, and also expand the laboratory acti vities. We have engaged our activity to also 
involve the planned, large population sutdy HUNT-3 with its biobank for pain research.

BIO-1.02.Food, Agriculture and Fisheries, and Biotechnology

Innovative non- intrusive laser gas sensors on food production for real time quality/safety in line control of food packaging and bottling systems

Tildelt: kr 3,0 mill.

Populærvitenskapelig framstilling

Sammendrag

Budsjettformål:

BIO-1.02.Food, Agriculture and Fisheries, and Biotechnology

Finansieringskilder

Temaer og emner